JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szallasi, A.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szallasi, A.
Right arrow Articles by Blumberg, P. M.

Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum

A Szallasi, NE Lewin and PM Blumberg

Molecular Mechanisms of Tumor Promotion Section, National Cancer Institute, Bethesda, Maryland.

We have used the vanilloid (capsaicin) receptor assay to search for modulators of binding activity. We report here that both capsaicin and its ultrapotent analog, resiniferatoxin (RTX), bind to the plasma protein alpha-1-acid glycoprotein (AGP) with high affinity (10.5 and 0.3 microM, respectively). AGP seems to be the dominant vanilloid (capsaicin/RTX) binding protein in serum. [3H] RTX binding to AGP is inhibited by chlorpromazine and by Trisbutoxyethylphosphate, indicating that vanilloids compete for a well-characterized drug binding domain on the AGP molecule. The 35-fold difference in the affinity of AGP for RTX and capsaicin may result in differences in the pharmacodynamics and pharmacokinetics of these two compounds; the contribution of AGP binding to the unique spectra of action of RTX or to the marked species differences in vanilloid actions, however, remains to be determined. An important practical application of AGP is its inclusion in the [3H]RTX binding assay utilizing sensory ganglion membranes to reduce nonspecific binding by up to 5-fold.

Volume 262, Issue 3, pp. 883-888, 09/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. R. Bianchi, R. El Kouhen, T. R. Neelands, C.-H. Lee, A. Gomtsyan, S. N. Raja, S. N. Vaidyanathan, B. Surber, H. A. McDonald, C. S. Surowy, et al.
[3H]A-778317 [1-((R)-5-tert-Butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a Novel, Stereoselective, High-Affinity Antagonist Is a Useful Radioligand for the Human Transient Receptor Potential Vanilloid-1 (TRPV1) Receptor
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi, et al.
Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1
Mol. Pharmacol., April 1, 2006; 69(4): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Jung, J. S. Shin, S.-Y. Lee, S. W. Hwang, J. Koo, H. Cho, and U. Oh
Phosphorylation of Vanilloid Receptor 1 by Ca2+/Calmodulin-dependent Kinase II Regulates Its Vanilloid Binding
J. Biol. Chem., February 20, 2004; 279(8): 7048 - 7054.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Jung, S.-Y. Lee, S. W. Hwang, H. Cho, J. Shin, Y.-S. Kang, S. Kim, and U. Oh
Agonist Recognition Sites in the Cytosolic Tails of Vanilloid Receptor 1
J. Biol. Chem., November 8, 2002; 277(46): 44448 - 44454.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wang, T. Szabo, J. D. Welter, A. Toth, R. Tran, J. Lee, S. U. Kang, Y.-G. Suh, P. M. Blumberg, and J. Lee
High Affinity Antagonists of the Vanilloid Receptor
Mol. Pharmacol., October 1, 2002; 62(4): 947 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. V. Kuzhikandathil, H. Wang, T. Szabo, N. Morozova, P. M. Blumberg, and G. S. Oxford
Functional Analysis of Capsaicin Receptor (Vanilloid Receptor Subtype 1) Multimerization and Agonist Responsiveness Using a Dominant Negative Mutation
J. Neurosci., November 15, 2001; 21(22): 8697 - 8706.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Szallasi, P. M. Blumberg, L. L. Annicelli, J. E. Krause, and D. N. Cortright
The Cloned Rat Vanilloid Receptor VR1 Mediates Both R-Type Binding and C-Type Calcium Response in Dorsal Root Ganglion Neurons
Mol. Pharmacol., September 1, 1999; 56(3): 581 - 587.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
A. Szallasi and P. M. Blumberg
Vanilloid (Capsaicin) Receptors and Mechanisms
Pharmacol. Rev., June 1, 1999; 51(2): 159 - 212.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Biro, M. Maurer, S. Modarres, N. E. Lewin, C. Brodie, G. Acs, P. Acs, R. Paus, and P. M. Blumberg
Characterization of Functional Vanilloid Receptors Expressed by Mast Cells
Blood, February 15, 1998; 91(4): 1332 - 1340.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Acs, T. Biro, P. Acs, S. Modarres, and P. M. Blumberg
Differential Activation and Desensitization of Sensory Neurons by Resiniferatoxin
J. Neurosci., July 15, 1997; 17(14): 5622 - 5628.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.